Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ECG Exercise Stress Test in Coronary Artery Disease
Author(s): Gaetano Antonio Lanza Added: 7 months ago

Guidelines & Statements
Echo-stress in Myocardial Bridge
Author(s): Priscilla Lamendola , Nello Cambise , Antonio Di Renzo , et al Added: 1 year ago

Prevention & Chronic Conditions
HFSA 24: STEP-HFpEF: Exercise Function and Frailty Status
Author(s): Mikhail Kosiborod Added: 1 year ago
HFSA 24 - We are joined virtually by Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) to discuss findings from the STEP-HFpEF trial programme in regard to the efficacy of semaglutide according to frailty status, and exercise function at baseline.Interview Questions:1. Could you remind us of the importance of STEP-HFpEF2. What was the study design and patient population?3. What… View more

Heart Failure

Prevention & Chronic Conditions
Author(s): Priscilla Lamendola , Nello Cambise , Antonio Di Renzo , et al Added: 1 year ago

Prevention & Chronic Conditions
Left Atrium Role in Secondary Mitral Regurgitation
Author(s): Markos Koukos , Yannis Dimitroglou , Dimitrios Tsartsalis , et al Added: 1 year ago

Vascular Disease and Surgery

Imaging & Diagnostics
Dr Purvi Parwani
Research Area(s) / Expertise:

Imaging & Diagnostics

Prevention & Chronic Conditions

 Job title: Cardiologist & Advanced Cardiovascular Imager
Dr Purvi Parwani is a cardiologist, multimodality imager and Associate Professor of Medicine at Loma Linda University in California. With board certification in Internal Medicine (2012), Nuclear Cardiology (2015), Echocardiography (2017) and Cardiovascular disease (2017), Dr. Parwani is a recognised expert in her field. Her research interests include cardiovascular imaging, structural… View more
EuroPCR 24: Ancillary SMART Trial Analyses
Author(s): Roxana Mehran Added: 1 year ago
EuroPCR 24 - Dr Roxana Mehran (Mount Sinai Hospital, US) joins us to discuss the findings from an ancillary analysis of the SMART trial (NCT04722250).The SMART trial is a prospective, multi-center, randomized controlled study that aims to investigate the valve safety and performance of self expanding as compared to balloon-expandable transcatheter aortic valve replacement (TAVR) in patients with… View more

Intervention
HFSA 25: Excercise Effects of Aficamten Vs Metoprolol in MAPLE-HCM
Author(s): Gregory Lewis Added: 3 months ago
HFSA 25 - Aficamten improves excercise capacity compared to metoprolol in patients with obstructive hypertrophic cardiomyopathy in a prespecified analysis of the MAPLE-HCM study.Dr Gregory Lewis joins us to discuss findings from a prespecified cardiopulmonary exercise testing analysis of the MAPLE-HCM trial, which reveals divergent effects between aficamten and metoprolol on exercise performance… View more

Heart Failure
ACC.24: The SMART Trial
Author(s): Howard C Herrmann Added: 1 year ago
ACC.24 — Investigator, Dr Howard C Hermann (Penn Medicine, Philadelphia, PA, US) joins us to discuss the findings from the SMART Trial (NCT04722250).This prospective, multi-center, randomized controlled study aims to investigate the valve safety and performance of self expanding as compared to balloon-expandable transcatheter aortic valve replacement (TAVR) in patients with small aortic annuli… View more

Intervention
Job title: Consultant Cardiologist
Dr Kenneth Morgan specalises in interventional and structural cardiology, with clinical expertise in transcatheter aortic valve implantation, chronic total occlusion angioplasty, and cardiac assessment for patients being evaluated for renal transplantation. He also serves as principal investigator for the Selution De Novo and Multivessel TALENT trials. View more